ATLAS / Macro Radar / Reporting / CBIO

CRESCENT BIOPHARMA, INC. (CBIO) reporting calendar

CRESCENT BIOPHARMA, INC. files periodic reports with the SEC as CBIO on Nasdaq. Atlas tracks 50 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
27 Jul 2026 – 24 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
29 Apr 2026
Reports on record
50

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CBIO market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202629 Apr 202629 days0001628280-26-028362
10-K31 Dec 202526 Feb 202657 days0001628280-26-011983
10-Q30 Sep 20256 Nov 202537 days0001628280-25-049868
10-Q30 Jun 202531 Jul 202531 days0001628280-25-036839
10-Q31 Mar 202514 May 202544 days0001558370-25-007780
10-K31 Dec 202413 Feb 202544 days0001558370-25-000948
10-Q30 Sep 202413 Nov 202444 days0001558370-24-015537
10-Q30 Jun 20248 Aug 202439 days0001558370-24-011579
10-Q31 Mar 20249 May 202439 days0001558370-24-007632
10-K31 Dec 202327 Mar 202487 days0001558370-24-004013
10-Q30 Sep 20233 Nov 202334 days0001558370-23-017505
10-Q30 Jun 20232 Aug 202333 days0001558370-23-012814
10-Q31 Mar 20233 May 202333 days0001558370-23-007744
10-K31 Dec 202229 Mar 202388 days0001558370-23-004864
10-Q30 Sep 20229 Nov 202240 days0001558370-22-017036
10-Q30 Jun 20223 Aug 202234 days0001558370-22-011770
10-Q31 Mar 202228 Apr 202228 days0001558370-22-006260
10-K31 Dec 20213 Mar 202262 days0001558370-22-002737
10-Q30 Sep 20212 Nov 202133 days0001558370-21-014003
10-Q30 Jun 20215 Aug 202136 days0001558370-21-010410
10-Q31 Mar 20213 May 202133 days0001558370-21-005473
10-K31 Dec 20202 Mar 202161 days0001558370-21-002222
10-Q30 Sep 20206 Nov 202037 days0001558370-20-013021
10-Q30 Jun 202031 Jul 202031 days0001558370-20-008841
10-Q31 Mar 20201 May 202031 days0001558370-20-004879
10-K31 Dec 201928 Feb 202059 days0001558370-20-001723
10-Q30 Sep 20197 Nov 201938 days0001558370-19-010290
10-Q30 Jun 20191 Aug 201932 days0001558370-19-006741
10-Q31 Mar 20192 May 201932 days0001558370-19-003803
10-K31 Dec 20186 Mar 201965 days0001558370-19-001537
10-Q30 Sep 20182 Nov 201833 days0001558370-18-008314
10-Q30 Jun 20189 Aug 201840 days0001558370-18-006888
10-Q31 Mar 20183 May 201833 days0001558370-18-003836
10-K31 Dec 20176 Mar 201865 days0001558370-18-001553
10-Q30 Sep 20178 Nov 201739 days0001558370-17-008486
10-Q30 Jun 20173 Aug 201734 days0001558370-17-005782
10-Q31 Mar 20178 May 201738 days0001558370-17-003731
10-K31 Dec 20161 Mar 201760 days0001558370-17-001198
10-Q30 Sep 20164 Nov 201635 days0001558370-16-009291
10-Q30 Jun 20164 Aug 201635 days0001558370-16-007379

Source: SEC EDGAR company submissions for CIK 0001253689. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.